← Leaderboards
Antonino Passaniti
University Of Maryland Baltimore
$1,328,420
Attributed
$1,328,420
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $263.6K · FY2006–24$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,328,420 · 2
VA$0 · 2
By mechanism
R01$1,031,420 · 1
R21$297,000 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Nancy G Fossett$2,742,265
- Priscilla A. Furth$6,008,619
- Jon Mark Hirshon$4,291,172
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthCell ProliferationNeoplastic CellTumor ProgressionBreast Cancer CellMolecularMissionNeoplasm MetastasisTherapeutic TargetTumor GrowthIn VivoTumorPathway InteractionsExhibitsCellsMediatingHealthcareAfrican AmericanHealthcare SystemsGlycolysisMalignant Breast NeoplasmMitochondriaGenesMetabolic
Grant awards (15)
Mitochondrial metabolism as a target of breast cancer therapy$0
I01 · FY2024 · VA · contact PI
Mitochondrial metabolism as a target of breast cancer therapy$0
I01 · FY2023 · VA · contact PI
Mitochondrial metabolism as a target of breast cancer therapy$0
I01 · FY2022 · VA · contact PI
Mitochondrial metabolism as a target of breast cancer therapy$0
I01 · FY2021 · VA · contact PI
Mitochondrial metabolism as a target of breast cancer therapy$0
I01 · FY2020 · VA · contact PI
Transcriptional regulation of tumor growth$0
I01 · FY2017 · VA · contact PI
Transcriptional regulation of tumor growth$0
I01 · FY2016 · VA · contact PI
Transcriptional regulation of tumor growth$0
I01 · FY2015 · VA · contact PI
Transcriptional regulation of tumor growth$0
I01 · FY2014 · VA · contact PI
Novel Transcriptional Regulators of Angiogenesis$255,944
R01 · FY2009 · CA · contact PI
Novel Transcriptional Regulators of Angiogenesis$255,944
R01 · FY2008 · CA · contact PI
Novel Transcriptional Regulators of Angiogenesis$255,944
R01 · FY2007 · CA · contact PI
Novel Transcriptional Regulators of Angiogenesis$263,588
R01 · FY2006 · CA · contact PI
Runx specific angiogenesis inhibitors$148,500
R21 · FY2003 · CA
Runx specific angiogenesis inhibitors$148,500
R21 · FY2002 · CA